Planet 13 Holdings (PLNH) Change in Account Payables (2022 - 2026)
Planet 13 Holdings (PLNH) reported Change in Account Payables of -$483957.0 for Q1 2026, up 69.44% year-over-year from -$285627.8 in Q1 2025, and up 7.43% quarter-over-quarter from -$522790.0 in Q3 2025.
Planet 13 Holdings (PLNH) Change in Account Payables (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Change in Account Payables data on file, last reported at -$483957.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$483957.0, up 69.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 138.33% YoY), and the FY2024 annual result was $4.3 million, up 1353.09% from the prior year.
- Change in Account Payables climbed to -$483957.0 in Q1 2026 per PLNH's latest filing, from -$522790.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.8 million in Q4 2024 and troughed at -$1.6 million in Q1 2025.
- A 5-year average of $264201.1 and a median of -$13497.5 in 2023 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 4743.38% in 2024 and fell as far as 133.51% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $387084.0 in 2022, then tumbled by 85.05% to $57858.0 in 2023, then soared by 4743.38% to $2.8 million in 2024, then slumped by 118.66% to -$522790.0 in 2025, then gained by 7.43% to -$483957.0 in 2026.
- Business Quant data shows PLNH's Change in Account Payables at -$483957.0 in Q1 2026, -$522790.0 in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | -483,957.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -483,957.00 |
| Mar 31, 2026 | -483,957.00 |
| Sep 30, 2025 | -522,790.00 |
| Sep 30, 2025 | -522,790.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.45 Mn |
| Jun 30, 2024 | -84,853.00 |
| Jun 30, 2024 | -84,853.00 |
| Mar 31, 2024 | -829,695.00 |
| Mar 31, 2024 | -829,695.00 |
| Dec 31, 2023 | 57,858.00 |
| Dec 31, 2023 | 57,858.00 |
| Sep 30, 2023 | -137,318.00 |
| Sep 30, 2023 | -137,318.00 |